ENDRA Life Sciences Inc. (NDRA)
USD 4.62
(0.87%)
USD 4.62
(0.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -9.54 Million | -12.76 Million | -11.12 Million | -10.77 Million | -8.58 Million | -7.7 Million |
| Net Income | -10.06 Million | -13.17 Million | -11.23 Million | -11.72 Million | -13.3 Million | -9.79 Million |
| Depreciation & Amortization | 275.45 Thousand | 234.25 Thousand | 224.41 Thousand | 165.24 Thousand | 115.01 Thousand | 68.31 Thousand |
| Deferred income taxes | 684.21 Thousand | - | - | -2.1 Million | -1399.55 | - |
| Stock-based compensation | 996.43 Thousand | 1.19 Million | 1.44 Million | 2.1 Million | 1399.55 | 1367.76 |
| Change in working capital | -923.31 Thousand | -1.02 Million | -1.26 Million | -1.54 Million | 597.83 Thousand | -359.08 Thousand |
| Other non-cash items | -521.3 Thousand | 1391.00 | -298.72 Thousand | 2.33 Million | 4 Million | 2.38 Million |
| Investing Cash Flow | -24.72 Thousand | -202.57 Thousand | -45 Thousand | -51.33 Thousand | -43.59 Thousand | -100 Thousand |
| Investments in PPE | -33.88 Thousand | -202.57 Thousand | -45 Thousand | -51.33 Thousand | -43.59 Thousand | -100 Thousand |
| Acquisitions | 9163.00 | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 9.16 | - | - | - | - | - |
| Financing Cash Flow | 7.51 Million | 8.39 Million | 13.4 Million | 11.87 Million | 8.33 Million | 8.67 Million |
| Debt repayment | - | - | - | -337.08 Thousand | -2.49 Million | -935.3 Thousand |
| Dividends payments | -840.00 | -7790.00 | -121.07 Thousand | -395.55 Thousand | -4.21 Million | - |
| Common Stock Repurchased | - | - | - | -337.08 Thousand | -2.49 Million | - |
| Common Stock Issuance | 7.51 Million | 8.39 Million | 10.61 Million | 6.78 Million | 125 Thousand | 7.73 Million |
| Other Financing Activities | 1.03 Million | 8399.51 | 2.78 Million | 5.76 Million | 13.19 Million | 935.3 Thousand |
| Accounts receivables | - | - | -491.1 Thousand | 834.99 Thousand | -760.14 Thousand | 6850.00 |
| Accounts payables | -822.25 Thousand | 111.57 Thousand | 491.1 Thousand | -834.99 Thousand | 760.14 Thousand | -6.18 Million |
| Inventory | -116.19 Thousand | -1.36 Million | -694.95 Thousand | -476.17 Thousand | -53.99 Thousand | -155.3 Thousand |
| Other working capital | 15.13 Thousand | 222.79 Thousand | -566.43 Thousand | -1.06 Million | 651.82 Thousand | 5.97 Million |
| Cash at beginning of period | 4.88 Million | 9.46 Million | 7.22 Million | 6.17 Million | 6.47 Million | 5.6 Million |
| Cash at end of period | 2.83 Million | 4.88 Million | 9.46 Million | 7.22 Million | 6.17 Million | 6.47 Million |
| Capital Expenditure | -33.88 Thousand | -202.57 Thousand | -45 Thousand | -51.33 Thousand | -43.59 Thousand | -100 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.05 Million | -4.57 Million | 2.23 Million | 1.05 Million | -297.16 Thousand | 869.49 Thousand |
| Free Cash Flow | -9.58 Million | -12.97 Million | -11.16 Million | -10.82 Million | -8.63 Million | -7.8 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.22 Million | -2.77 Million | -1.45 Million | -10.06 Million | -3.1 Million | -2.55 Million |
| Depreciation & Amortization | 50.12 Thousand | 55.67 Thousand | 61.24 Thousand | 275.45 Thousand | 70.44 Thousand | 72.71 Thousand |
| Deferred income taxes | - | - | -1.64 Million | 684.21 Thousand | -262.83 Thousand | -227.75 Thousand |
| Stock-based compensation | 186.59 Thousand | 317.49 Thousand | 250.55 Thousand | 996.43 Thousand | 252.73 Thousand | 255.85 Thousand |
| Change in working capital | 47.18 Thousand | 106.67 Thousand | -1.18 Million | -923.31 Thousand | 178.89 Thousand | -40.03 Thousand |
| Other non-cash items | -118.22 Thousand | 474.47 Thousand | 1.81 Million | -521.3 Thousand | 262.83 Thousand | 227.75 Thousand |
| Investing Cash Flow | 11 Thousand | -23.79 Thousand | 2279.00 | -24.72 Thousand | - | - |
| Investments in PPE | 11 Thousand | -27 Thousand | -6884.00 | -33.88 Thousand | - | - |
| Acquisitions | - | 3204.00 | 9163.00 | 9163.00 | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 3204.00 | 9.16 | 9.16 | - | - |
| Financing Cash Flow | 7.33 Million | 468.9 Thousand | 1.67 Million | 7.51 Million | 1.11 Million | 4.73 Million |
| Debt repayment | - | -28.48 Thousand | - | - | - | - |
| Dividends payments | - | -4932.00 | -840.00 | -840.00 | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.33 Million | 497.38 Thousand | 1.67 Million | 7.51 Million | 1.11 Million | 4.71 Million |
| Other Financing Activities | 6.6 Million | 53.86 Thousand | 1671.67 | 1.03 Million | 1113.83 | 20.05 Thousand |
| Accounts receivables | - | - | 195.81 Thousand | - | - | -195.81 Thousand |
| Accounts payables | 128.96 Thousand | 337.71 Thousand | -1.27 Million | -822.25 Thousand | 130.8 Thousand | 195.81 Thousand |
| Inventory | 138.04 Thousand | -231.79 Thousand | -3277.00 | -116.19 Thousand | - | -22.28 Thousand |
| Other working capital | -219.83 Thousand | 754.00 | 85.12 Thousand | 15.13 Thousand | 48.09 Thousand | -17.74 Thousand |
| Cash at beginning of period | 1.13 Million | 2.83 Million | 3.33 Million | 4.88 Million | 4.81 Million | 2.35 Million |
| Cash at end of period | 6.4 Million | 1.13 Million | 2.83 Million | 2.83 Million | 3.33 Million | 4.81 Million |
| Capital Expenditure | 11 Thousand | -27 Thousand | -6884.00 | -33.88 Thousand | - | - |
| Effect of forex changes on cash | - | - | -2381.00 | - | - | - |
| Net cash flow / Change in cash | 5.26 Million | -1.69 Million | -500.62 Thousand | -2.05 Million | -1.48 Million | 2.46 Million |
| Free Cash Flow | -2.07 Million | -2.17 Million | -2.18 Million | -9.58 Million | -2.59 Million | -2.26 Million |
300403
688103
KYYWF
688110
GALADAFIN
AZRG